HYEWON JUNG: Open Payments
NPI 1477940542 · NEW HYDE PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $266 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $169 |
| Astellas Pharma US Inc | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Genmab U.S., Inc. | 1 | $27 |
| Geron Corporation | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| TerSera Therapeutics LLC | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: CALQUENCE, Vyloy, JEMPERLI, Tivdak, RYTELO, ULTOMIRIS, Zoladex, LYNPARZA.
Industry payments across NY — which companies pay providers there.
